News
FDA approves drug for rare lung disease
On May 28, the U.S. Food and Drug Administration (FDA) approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis, a rare, progressive lung disease that primarily affects…
FDA approves treatments for irritable bowel syndrome
On May 27, the U.S. Food and Drug Administration (FDA) approved Viberzi (eluxadoline) and Xifaxan (rifaximin) for irritable bowel syndrome with diarrhea in adult…
FDA approves new spinal cord stimulation system for pain
On May 8, the U.S. Food and Drug Administration (FDA) approved the Senza spinal cord stimulation (SCS) system to help manage chronic intractable pain…
FDA approves Raplixa to help control bleeding during surgery
On April 30, the U.S. Food and Drug Administration (FDA) approved Raplixa (fibrin sealant [human]), the first spray-dried fibrin sealant approved by the agency.…
FDA approves generic Abilify
On April 28, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Abilify (aripiprazole). Read more.
FDA approves drug for rare lung disease
On May 28, the U.S. Food and Drug Administration (FDA) approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis, a rare, progressive lung disease that…
FDA approves treatments for irritable bowel syndrome
On May 27, the U.S. Food and Drug Administration (FDA) approved Viberzi (eluxadoline) and Xifaxan (rifaximin) for irritable bowel syndrome with diarrhea…
FDA approves new spinal cord stimulation system for pain
On May 8, the U.S. Food and Drug Administration (FDA) approved the Senza spinal cord stimulation (SCS) system to help manage chronic…
FDA approves Raplixa to help control bleeding during surgery
On April 30, the U.S. Food and Drug Administration (FDA) approved Raplixa (fibrin sealant [human]), the first spray-dried fibrin sealant approved by…
FDA approves generic Abilify
On April 28, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Abilify (aripiprazole). Read more.
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.